Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kenemans

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Menopause (New York, N.Y.)|January 13, 2004
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal womenTatjana E Vogelvang, Judith R Leurs, Marius J van der Mooren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal womenMarinka S Post, M Christella, L G D Thomassen, et al.
The Journal of Pathology|May 10, 2005
Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancerBrenda B J Hermsen, Silvia von Mensdorff-Pouilly, Hans F J Fabry, et al.
Menopause (New York, N.Y.)|July 23, 2005
Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind studyMarieke O Verhoeven, Marius J van der Mooren, Peter H M van de Weijer, et al.
Menopause (New York, N.Y.)|November 25, 2003
Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled studyMajoie Hemelaar, Marius J van der Mooren, Velja Mijatovic, et al.
Gynecologic Oncology|November 15, 2008
SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancerJonas van de Lande, Elvira M Davelaar, Silvia von Mensdorff-Pouilly, et al.
Annals of Clinical Biochemistry|April 22, 2010
Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomyHong N Bui, Eduard A Struys, Frans Martens, et al.
Maturitas|February 12, 2002
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteineRaimond G V Smolders, Tatjana E Vogelvang, Velja Mijatovic, et al.
Familial Cancer|October 24, 2003
Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based studyJurgen M J Piek, Bas Torrenga, Brenda Hermsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancerBrenda B J Hermsen, Silvia von Mensdorff-Pouilly, Johannes Berkhof, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Menopause (New York, N.Y.)|January 13, 2004
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal womenTatjana E Vogelvang, Judith R Leurs, Marius J van der Mooren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal womenMarinka S Post, M Christella, L G D Thomassen, et al.
The Journal of Pathology|May 10, 2005
Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancerBrenda B J Hermsen, Silvia von Mensdorff-Pouilly, Hans F J Fabry, et al.
Menopause (New York, N.Y.)|July 23, 2005
Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind studyMarieke O Verhoeven, Marius J van der Mooren, Peter H M van de Weijer, et al.
Menopause (New York, N.Y.)|November 25, 2003
Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled studyMajoie Hemelaar, Marius J van der Mooren, Velja Mijatovic, et al.
Gynecologic Oncology|November 15, 2008
SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancerJonas van de Lande, Elvira M Davelaar, Silvia von Mensdorff-Pouilly, et al.
Annals of Clinical Biochemistry|April 22, 2010
Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomyHong N Bui, Eduard A Struys, Frans Martens, et al.
Maturitas|February 12, 2002
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteineRaimond G V Smolders, Tatjana E Vogelvang, Velja Mijatovic, et al.
Familial Cancer|October 24, 2003
Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based studyJurgen M J Piek, Bas Torrenga, Brenda Hermsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancerBrenda B J Hermsen, Silvia von Mensdorff-Pouilly, Johannes Berkhof, et al.
Pageof 7